Circassia Pharmaceuticals's market cap is currently £244.02M. The company's EPS TTM is p0.027; its P/E ratio is 22.09; and it has a dividend yield of 1.64%. Circassia Pharmaceuticals is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	£ 36.80M	£ 31.30M	£ 27.90M	£ 23.90M	£ 34.60M
Gross Profit	£ 26.50M	£ 22.20M	£ 19.00M	£ 16.30M	£ 25.50M
Operating Income	£ 4.60M	£ 1.80M	£ -4.30M	£ -17.30M	£ -18.50M
EBITDA	£ 8.70M	£ 15.40M	£ 3.10M	£ -9.10M	£ -12.10M
Net Income	£ 10.70M	£ 16.10M	£ 3.60M	£ -33.50M	£ -16.80M
Balance Sheet
Cash & Short-Term Investments	£ 19.90M	£ 19.40M	£ 12.60M	£ 7.40M	£ 27.00M
Total Assets	£ 91.50M	£ 98.50M	£ 86.40M	£ 103.10M	£ 246.80M
Total Debt	£ 1.10M	£ 1.00M	£ 1.30M	£ 1.60M	£ 111.40M
Net Debt	£ -18.80M	£ -18.40M	£ -11.30M	£ -5.80M	£ 84.40M
Total Liabilities	£ 7.70M	£ 16.60M	£ 19.60M	£ 37.00M	£ 162.00M
Stockholders' Equity	£ 83.80M	£ 81.90M	£ 66.80M	£ 66.10M	£ 84.80M
Cash Flow
Free Cash Flow	£ 11.30M	£ 6.60M	£ 1.20M	£ -24.40M	£ -25.40M
Operating Cash Flow	£ 11.60M	£ 6.70M	£ 1.40M	£ -23.90M	£ -25.10M
Investing Cash Flow	£ -300.00K	£ -100.00K	£ -200.00K	£ -500.00K	£ -9.90M
Financing Cash Flow	£ -10.50M	£ -500.00K	£ 4.10M	£ 4.30M	£ 21.90M

Currency in GBP

Circassia Pharmaceuticals Earnings and Revenue History

Income Statement >

Circassia Pharmaceuticals Debt to Assets

Balance Sheet >

Circassia Pharmaceuticals Cash Flow

Cash Flow >

Circassia Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing